Table 3 Comparison of ThyPRO scale scores between subclinical and overt hypothyroidism and comparison of ThyPRO scale scores between group A (decrease in plasma FT3I after initiation of levothyroxine) and group B (increase or no change in plasma FT3I after initiation of levothyroxine)

Composite score

37.8 ± 19.7

36.3 ± 18.3

1.5 [-7.8 to 10.9]

0.741

42.7 ± 19.9

33.9 ± 17.8

8.7 [-1.2 to 18.5]

0.084

Goitre symptoms

18.6 ±  ± 18.5

13.7 ± 10.8

4.9 [-2.4 to 12.2]

0.186

13.9 ± 16.6

17.6 ± 14.9

-3.7 [-11.9 to 4.5]

0.155

Hypothyroid symptoms

38.7 ± 24.8

26.0 ± 21.8

12.7^a [1.3 to 24.2]

.0290

32.6 ± 22.4

32.9 ± 25.3

-0.4 [-12.5 to 11.6]

0.818

Tiredness

64.1 ± 23.6

56.8 ± 23.1

7.4 [-4.1 to 18.7]

0.202

62.5 ± 24.8

59.7 ± 22.9

2.7 [-9.6 to 15.1]

0.519

Cognitive complaints

32.9 ± 24.3

29.9 ± 24.2

3.0 [-8.9 to 14.8]

0.615

34.5 ± 21.9

29.9 ± 25.3

4.5 [-7.4 to 16.3]

0.343

Anxiety

28.9 ± 22.9

30.0 ± 19.9

-1.1 [-11.5 to 9.4]

0.841

38.1 ± 24.8

24.5 ± 17.9

13.5^a [3.1 to 24.0]

0.032

Depressivity

31.2 ± 19.2

34.9 ± 17.5

-3.8 [-12.7 to 5.2]

0.404

38.3 ± 21.4

29.9 ± 16.0

8.3^a [0.8 to 17.5]

0.110

Emotional susceptibility

42.6 ± 24.2

43.1 ± 20.0

-0.5 [-11.3 to 10.3]

0.925

50.7 ± 22.3

38.4 ± 21.1

12.3^a [1.4 to 23.5]

0.035

Impaired social life

18.9 ± 22.1

16.7 ± 20.2

2.3 [-8.0 to 12.5]

0.662

24.3 ± 24.9

14.3 ± 17.9

9.9^a (0.6 to 20.5]

0.126

Impaired daily life

28.5 ± 24.9

28.2 ± 24.9

0.3 [-11.9 to 12.5]

0.957

32.0 ± 24.6

26.4 ± 24.8

5.6 [-6.9 to 18.3]

0.379

Overall quality of life

45.8 ± 32.5

40.3 ± 30.1

5.5 [-9.7 to 20.7]

0.473

48.9 ± 32.5

40.1 ± 30.4

8.8 [-7.5 to 25.1]

0.297